A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Pfizer
AstraZeneca
AstraZeneca
Genmab
Incyte Corporation
Leap Therapeutics, Inc.
Precision Biologics, Inc
Revolution Medicines, Inc.
Elevation Oncology
Karyopharm Therapeutics Inc
Mabwell (Shanghai) Bioscience Co., Ltd.
Advaxis, Inc.
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Gradalis, Inc.
Revolution Medicines, Inc.
Pfizer
CytoCore, Inc.
ImmunoFrontier, Inc.
Cook Group Incorporated
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Xoft, Inc.
Boston Scientific Corporation
Novartis
Astellas Pharma Inc
Takeda
Eli Lilly and Company
Sanofi
Amgen
Eli Lilly and Company